Isovurex

Ezetimibe, the active ingredient in Isovurex, is a cholesterol absorption inhibitor presented as an oral tablet for oral use. It lowers low‑density lipoprotein cholesterol and is indicated for patients with hypercholesterolemia or mixed dyslipidemia, either alone or in combination with statins.

GNH USA supplies Isovurex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isovurex is a cholesterol absorption inhibitor used to manage disorders of lipid metabolism. - Hypercholesterolemia: reduces LDL‑C levels as monotherapy or together with a statin. - Mixed dyslipidemia: lowers total cholesterol, LDL‑C and triglycerides while modestly increasing HDL‑C. - Statin‑intolerant patients with primary hypercholesterolemia: provides an alternative pathway for LDL‑C reduction.

Adverse reactions to ezetimibe are generally mild, but clinicians should be aware of both common and serious possibilities.

Common Side Effects: - Abdominal pain: mild to moderate discomfort in the stomach area. - Diarrhea: loose stools occurring intermittently. - Fatigue: a feeling of tiredness not explained by other causes. - Headache: mild to moderate pain in the head. - Muscle pain: occasional soreness or aching. - Nausea: sensation of needing to vomit.

Serious or Rare Side Effects: - Elevated liver enzymes: may indicate hepatic stress, especially when combined with statins. - Myopathy or rhabdomyysis: severe muscle breakdown, rare but serious. - Allergic reactions: rash, pruritus, or angioedema. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain and vomiting.

Before initiating therapy, several safety considerations should be reviewed. - Baseline lipid assessment: document LDL‑C, HDL‑C and triglycerides. - Liver function monitoring: check ALT/AST periodically, especially with statin co‑therapy. - Gallbladder disease evaluation: ezetimibe may affect bile composition. - Concomitant statin use: assess risk of myopathy and adjust doses if needed. - Storage: Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ezetimibe may interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Bile‑acid sequestrants (e.g., cholestyramine, colestipol): markedly reduce ezetimibe absorption. - High‑dose statins (e.g., rosuvastatin ≥40 mg): increase risk of myopathy.

Moderate Interactions (Monitor Closely): - Fibrates (gemfibrozil, fenofibrate): may raise liver enzyme levels. - Cyclosporine: can increase ezetimibe plasma concentrations. - Warfarin: monitor INR as ezetimibe may affect anticoagulation control.